Ovarian Cancer Trial, Recruiting (NCT06272240)

Ovarian Cancer Trial, Recruiting NCT06272240 Sponsor: University of Udine Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06272240 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are older than 18 years of age
You are younger than 80 years of age
You have been diagnosed with serous ovarian carcinoma (a specific type of ovarian cancer)
Your cancer is classified as Stage III or Stage IV (meaning it has spread beyond the ovary)

Who may not be able to join:

You are currently taking, or have recently taken (within the last 6 months), medication that suppresses your immune system
You have a condition — either one you were born with or developed — that weakens your immune system
You are in a state where your immune system is not working properly (confirm with trial site)
You have received chemotherapy for a different cancer within the past 12 months
Your ovarian tumour is a non-epithelial type (a different kind of ovarian tumour that does not start in the surface cells of the ovary)
You are not planning to have surgery as part of your treatment
Your Body Mass Index (BMI) — a measure of body weight relative to height — is over 30
You are unwilling or unable to give your informed consent (your formal agreement to take part in the trial)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 3403990822

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06272240

Sponsor: University of Udine

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 3403990822

More information: https://clinicaltrials.gov/study/NCT06272240

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are older than 18 years of age
You are younger than 80 years of age
You have been diagnosed with serous ovarian carcinoma (a specific type of ovarian cancer)
Your cancer is classified as Stage III or Stage IV (meaning it has spread beyond the ovary)

Who may not be able to join:

You are currently taking, or have recently taken (within the last 6 months), medication that suppresses your immune system
You have a condition — either one you were born with or developed — that weakens your immune system
You are in a state where your immune system is not working properly (confirm with trial site)
You have received chemotherapy for a different cancer within the past 12 months
Your ovarian tumour is a non-epithelial type (a different kind of ovarian tumour that does not start in the surface cells of the ovary)
You are not planning to have surgery as part of your treatment
Your Body Mass Index (BMI) — a measure of body weight relative to height — is over 30
You are unwilling or unable to give your informed consent (your formal agreement to take part in the trial)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Udine

Registry

ClinicalTrials.gov

Start date

2 January 2024

Est. completion

1 July 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

• Composition of the tumor microenvironment (including the immune system and intratumoral microbiota). • Generate organoids

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov